Other meanings of Tissue engineering
Biomedical Engineering
Tissue engineering is a biomedical field that combines cells, scaffolds, and biochemical signals to create functional substitutes for damaged or diseased tissues. It aims to repair, replace, or regenerate biological tissues, often using a combination of living cells, biomaterials, and growth factors. The field emerged in the late 20th century, building on principles from cell biology, materials science, and surgery. A landmark achievement was the 1997 implantation of a tissue-engineered bladder in a human patient by Anthony Atala and colleagues, demonstrating the clinical potential of the approach.
Tissue engineering relies on three fundamental elements: cells, scaffolds, and biochemical signals. Cells are typically autologous (from the patient) or stem cells, which can differentiate into the desired tissue type. Scaffolds are porous biomaterials that provide structural support and guide tissue formation; they can be natural (e.g., collagen, alginate) or synthetic (e.g., polylactic acid, polyglycolic acid). Signals include growth factors and mechanical stimuli that direct cell behavior. The combination is cultured in a bioreactor to promote tissue maturation before implantation. The goal is to create a living construct that integrates with the host and restores function.
The concept of replacing tissues dates back to ancient times, but modern tissue engineering emerged in the 1980s and 1990s. The term was formally defined in 1993 by Robert Langer and Joseph Vacanti, who described it as an interdisciplinary field applying engineering principles to biological systems. Early successes included skin substitutes for burn victims and cartilage repair. A landmark was the 1997 implantation of a bladder grown from a patient's own cells, reported by Anthony Atala. Subsequent advances have included engineered tracheas, blood vessels, and even heart valves. However, clinical translation has been slow due to challenges in vascularization and long-term stability.
Current applications span many tissue types: skin, bone, cartilage, blood vessels, and even organs like the liver and kidney. Research focuses on improving scaffold design, using 3D bioprinting to create complex structures, and developing organ-on-a-chip models for drug testing. Stem cell technology, particularly induced pluripotent stem cells, offers new sources for patient-specific tissues. Recent advances include the use of decellularized matrices and the development of smart biomaterials that respond to environmental cues. Despite progress, challenges remain in scaling up production, ensuring immune compatibility, and achieving functional integration with the host.
Beyond the well-known applications, tissue engineering has niche uses such as creating meat in the lab (cultured meat), which is being developed as a sustainable food source. Another lesser-known area is the use of tissue engineering for space medicine, where microgravity affects tissue growth. The field also intersects with ethics, particularly regarding the use of embryonic stem cells and the creation of chimeras. A notable historical figure is Charles Vacanti, who co-founded the field and was involved in the controversial ear-on-mouse experiment. Additionally, tissue engineering has been explored for preserving endangered species by creating gametes from stem cells.
Tissue engineering is a rapidly evolving field with potential to transform medicine, but it also raises ethical and regulatory questions that require careful consideration.
Help improve the encyclopedia. Reports go straight to the site manager.